| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonography, Computed Tomographic | 57 | 2024 | 81 | 13.700 |
Why?
|
| Colonic Polyps | 34 | 2024 | 126 | 6.620 |
Why?
|
| Colorectal Neoplasms | 20 | 2020 | 938 | 2.920 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 18 | 2020 | 466 | 2.460 |
Why?
|
| Tomography, X-Ray Computed | 41 | 2020 | 2601 | 2.100 |
Why?
|
| Colonic Neoplasms | 18 | 2014 | 556 | 1.750 |
Why?
|
| Sensitivity and Specificity | 38 | 2020 | 1991 | 1.360 |
Why?
|
| Imaging, Three-Dimensional | 17 | 2020 | 579 | 1.230 |
Why?
|
| Diagnostic Errors | 6 | 2017 | 160 | 1.120 |
Why?
|
| Radiography, Abdominal | 4 | 2022 | 71 | 1.040 |
Why?
|
| Mass Screening | 8 | 2020 | 618 | 1.000 |
Why?
|
| Colon | 14 | 2020 | 496 | 0.940 |
Why?
|
| Humans | 132 | 2024 | 86644 | 0.850 |
Why?
|
| Abdominal Pain | 3 | 2020 | 137 | 0.790 |
Why?
|
| False Negative Reactions | 6 | 2020 | 63 | 0.780 |
Why?
|
| Colonoscopy | 9 | 2011 | 264 | 0.780 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2005 | 1204 | 0.720 |
Why?
|
| Quality Control | 2 | 2018 | 117 | 0.700 |
Why?
|
| Pattern Recognition, Automated | 7 | 2014 | 217 | 0.680 |
Why?
|
| Radiation Dosage | 3 | 2022 | 227 | 0.670 |
Why?
|
| Pancreas | 5 | 2013 | 239 | 0.630 |
Why?
|
| Radiographic Image Enhancement | 6 | 2012 | 462 | 0.600 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.590 |
Why?
|
| Movement | 2 | 2011 | 299 | 0.570 |
Why?
|
| Appendix | 3 | 2012 | 31 | 0.570 |
Why?
|
| Multidetector Computed Tomography | 2 | 2017 | 54 | 0.560 |
Why?
|
| Appendicitis | 2 | 2017 | 62 | 0.550 |
Why?
|
| Algorithms | 7 | 2010 | 1830 | 0.550 |
Why?
|
| Middle Aged | 52 | 2020 | 25028 | 0.550 |
Why?
|
| Male | 65 | 2020 | 40966 | 0.520 |
Why?
|
| Professional Competence | 2 | 2012 | 68 | 0.510 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.510 |
Why?
|
| False Positive Reactions | 8 | 2020 | 216 | 0.510 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.510 |
Why?
|
| Adenocarcinoma | 7 | 2009 | 1169 | 0.500 |
Why?
|
| Reproducibility of Results | 15 | 2016 | 2705 | 0.500 |
Why?
|
| Intestinal Obstruction | 3 | 2007 | 88 | 0.490 |
Why?
|
| Cecum | 3 | 2020 | 68 | 0.470 |
Why?
|
| Lung | 1 | 2020 | 1170 | 0.470 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 59 | 0.460 |
Why?
|
| Female | 63 | 2019 | 44533 | 0.450 |
Why?
|
| Radiography | 13 | 2022 | 813 | 0.440 |
Why?
|
| Contrast Media | 8 | 2020 | 1078 | 0.440 |
Why?
|
| Air | 1 | 2012 | 62 | 0.440 |
Why?
|
| Renal Artery | 2 | 2011 | 64 | 0.420 |
Why?
|
| Colonic Diseases | 2 | 2007 | 65 | 0.420 |
Why?
|
| Aged | 34 | 2020 | 18415 | 0.420 |
Why?
|
| Technology, Radiologic | 1 | 2012 | 103 | 0.420 |
Why?
|
| Health Policy | 1 | 2013 | 180 | 0.410 |
Why?
|
| Adult | 43 | 2020 | 25648 | 0.400 |
Why?
|
| Cathartics | 2 | 2011 | 27 | 0.390 |
Why?
|
| Observer Variation | 8 | 2012 | 602 | 0.390 |
Why?
|
| Kidney | 3 | 2011 | 1241 | 0.390 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2001 | 16 | 0.380 |
Why?
|
| Citric Acid | 2 | 2011 | 38 | 0.380 |
Why?
|
| Collateral Circulation | 2 | 2001 | 35 | 0.380 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2000 | 106 | 0.370 |
Why?
|
| Intestine, Small | 2 | 2007 | 303 | 0.370 |
Why?
|
| Body Mass Index | 2 | 2013 | 770 | 0.360 |
Why?
|
| Organometallic Compounds | 2 | 2011 | 132 | 0.360 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 394 | 0.360 |
Why?
|
| Liver Neoplasms | 10 | 2005 | 736 | 0.360 |
Why?
|
| Neurofibromatosis 1 | 2 | 2000 | 36 | 0.350 |
Why?
|
| Postoperative Complications | 5 | 2019 | 2207 | 0.350 |
Why?
|
| Ultrasonography | 19 | 2002 | 695 | 0.340 |
Why?
|
| Portal Vein | 3 | 2001 | 120 | 0.330 |
Why?
|
| Insufflation | 2 | 2006 | 10 | 0.330 |
Why?
|
| Calcinosis | 7 | 2001 | 224 | 0.330 |
Why?
|
| United States | 16 | 2020 | 6672 | 0.320 |
Why?
|
| Diagnostic Imaging | 3 | 2009 | 469 | 0.320 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 663 | 0.320 |
Why?
|
| Incidental Findings | 1 | 2008 | 95 | 0.310 |
Why?
|
| Diagnosis, Differential | 17 | 2014 | 1565 | 0.310 |
Why?
|
| Diverticulum | 2 | 2024 | 44 | 0.310 |
Why?
|
| Supine Position | 4 | 2011 | 30 | 0.310 |
Why?
|
| Liver Cirrhosis | 4 | 2006 | 297 | 0.300 |
Why?
|
| Adenoma | 6 | 2014 | 235 | 0.300 |
Why?
|
| Retrospective Studies | 18 | 2019 | 8489 | 0.300 |
Why?
|
| Aged, 80 and over | 14 | 2014 | 6509 | 0.300 |
Why?
|
| Prone Position | 4 | 2011 | 56 | 0.290 |
Why?
|
| Societies, Medical | 2 | 2016 | 572 | 0.290 |
Why?
|
| Abdominal Neoplasms | 3 | 2013 | 39 | 0.290 |
Why?
|
| Dietary Fiber | 1 | 2006 | 43 | 0.280 |
Why?
|
| Enema | 3 | 2005 | 37 | 0.280 |
Why?
|
| Image Enhancement | 4 | 2010 | 563 | 0.280 |
Why?
|
| Software | 5 | 2011 | 654 | 0.280 |
Why?
|
| Varicose Veins | 1 | 2006 | 10 | 0.280 |
Why?
|
| Rectum | 3 | 2020 | 146 | 0.280 |
Why?
|
| Ileocecal Valve | 1 | 2006 | 5 | 0.280 |
Why?
|
| Intestinal Perforation | 1 | 2006 | 34 | 0.280 |
Why?
|
| Hypertension, Portal | 1 | 2006 | 47 | 0.270 |
Why?
|
| Fluoroscopy | 3 | 1998 | 119 | 0.270 |
Why?
|
| Pericardium | 1 | 2006 | 65 | 0.270 |
Why?
|
| Internet | 1 | 2008 | 312 | 0.270 |
Why?
|
| Computer-Aided Design | 1 | 2005 | 18 | 0.260 |
Why?
|
| Feces | 1 | 2006 | 319 | 0.250 |
Why?
|
| Liver | 4 | 1999 | 1230 | 0.250 |
Why?
|
| Artificial Intelligence | 3 | 2008 | 298 | 0.240 |
Why?
|
| Thoracic Neoplasms | 2 | 2001 | 64 | 0.230 |
Why?
|
| Deglutition Disorders | 3 | 2018 | 115 | 0.230 |
Why?
|
| User-Computer Interface | 2 | 2002 | 185 | 0.230 |
Why?
|
| Publishing | 1 | 2004 | 90 | 0.220 |
Why?
|
| Ganglioneuroma | 2 | 2000 | 9 | 0.210 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 220 | 0.210 |
Why?
|
| Radiologists | 1 | 2022 | 46 | 0.210 |
Why?
|
| Cohort Studies | 5 | 2012 | 2767 | 0.210 |
Why?
|
| General Surgery | 1 | 2004 | 229 | 0.200 |
Why?
|
| Radiology | 3 | 2010 | 194 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 1036 | 0.200 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2001 | 20 | 0.200 |
Why?
|
| Mesenteric Veins | 1 | 2001 | 34 | 0.200 |
Why?
|
| Registries | 3 | 2020 | 702 | 0.200 |
Why?
|
| Gastrointestinal Diseases | 1 | 2002 | 146 | 0.190 |
Why?
|
| Predictive Value of Tests | 6 | 2012 | 1673 | 0.190 |
Why?
|
| Splenic Neoplasms | 2 | 1998 | 16 | 0.180 |
Why?
|
| Pulmonary Veins | 1 | 2000 | 72 | 0.180 |
Why?
|
| Esophagitis | 2 | 1991 | 42 | 0.170 |
Why?
|
| Polyps | 3 | 2007 | 28 | 0.170 |
Why?
|
| Hernia, Ventral | 1 | 1999 | 24 | 0.170 |
Why?
|
| Laser Therapy | 2 | 1990 | 142 | 0.160 |
Why?
|
| Colonic Pouches | 1 | 2019 | 67 | 0.160 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2018 | 16 | 0.160 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2019 | 87 | 0.160 |
Why?
|
| Subthalamic Nucleus | 1 | 2018 | 22 | 0.160 |
Why?
|
| Surgical Mesh | 1 | 1999 | 116 | 0.160 |
Why?
|
| Biopsy, Needle | 1 | 1998 | 235 | 0.160 |
Why?
|
| Pancreas Transplantation | 1 | 1998 | 103 | 0.160 |
Why?
|
| Radiography, Interventional | 2 | 1998 | 150 | 0.160 |
Why?
|
| Intestinal Diseases | 3 | 1994 | 79 | 0.160 |
Why?
|
| Ischemia | 1 | 1999 | 243 | 0.160 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 54 | 0.150 |
Why?
|
| Pelvic Neoplasms | 2 | 2013 | 45 | 0.150 |
Why?
|
| Reference Values | 2 | 2012 | 674 | 0.150 |
Why?
|
| Pandemics | 2 | 2020 | 740 | 0.150 |
Why?
|
| Bile Ducts | 2 | 1990 | 59 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 383 | 0.150 |
Why?
|
| Laparoscopy | 2 | 2006 | 754 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2018 | 132 | 0.140 |
Why?
|
| Malpractice | 1 | 2017 | 57 | 0.140 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 320 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 3362 | 0.140 |
Why?
|
| Iodides | 1 | 1995 | 18 | 0.140 |
Why?
|
| Documentation | 1 | 2016 | 98 | 0.140 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1998 | 261 | 0.130 |
Why?
|
| Peritoneal Diseases | 2 | 2013 | 15 | 0.130 |
Why?
|
| Living Donors | 1 | 1998 | 339 | 0.130 |
Why?
|
| Occult Blood | 1 | 1994 | 16 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2011 | 751 | 0.130 |
Why?
|
| Carcinoma, Small Cell | 1 | 1995 | 134 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 1998 | 849 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2016 | 217 | 0.130 |
Why?
|
| Cross-Over Studies | 2 | 2018 | 399 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2001 | 744 | 0.120 |
Why?
|
| Neoplasms | 1 | 2009 | 2898 | 0.120 |
Why?
|
| ROC Curve | 4 | 2010 | 752 | 0.120 |
Why?
|
| Colitis, Ulcerative | 2 | 2019 | 711 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 297 | 0.120 |
Why?
|
| Metformin | 1 | 1995 | 128 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 4 | 2005 | 645 | 0.120 |
Why?
|
| Barium Sulfate | 4 | 2005 | 43 | 0.120 |
Why?
|
| Rectal Neoplasms | 2 | 2000 | 116 | 0.120 |
Why?
|
| Incidence | 3 | 2013 | 1577 | 0.110 |
Why?
|
| Time Factors | 6 | 2018 | 5210 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2013 | 85 | 0.110 |
Why?
|
| Intestinal Polyps | 3 | 2006 | 26 | 0.110 |
Why?
|
| Gallstones | 1 | 1992 | 14 | 0.110 |
Why?
|
| Mesentery | 1 | 2013 | 45 | 0.110 |
Why?
|
| Radiology Information Systems | 2 | 2016 | 76 | 0.110 |
Why?
|
| Hodgkin Disease | 1 | 1994 | 177 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 1995 | 378 | 0.110 |
Why?
|
| Choristoma | 1 | 2013 | 68 | 0.110 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 48 | 0.110 |
Why?
|
| Pancreatitis | 1 | 2013 | 87 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1987 | 384 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1994 | 229 | 0.100 |
Why?
|
| Prevalence | 3 | 2014 | 1239 | 0.100 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1991 | 33 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2018 | 4214 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 173 | 0.100 |
Why?
|
| Age Distribution | 1 | 2012 | 204 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2006 | 332 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2006 | 839 | 0.100 |
Why?
|
| Intestinal Neoplasms | 2 | 1994 | 56 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 1999 | 1268 | 0.100 |
Why?
|
| Electrolytes | 1 | 2011 | 52 | 0.100 |
Why?
|
| Esophageal Neoplasms | 2 | 1991 | 321 | 0.100 |
Why?
|
| Organ Size | 1 | 2012 | 364 | 0.100 |
Why?
|
| Esophagus | 1 | 1991 | 102 | 0.100 |
Why?
|
| Health Care Costs | 1 | 2013 | 238 | 0.100 |
Why?
|
| Hemangioma | 2 | 1988 | 60 | 0.100 |
Why?
|
| Quality of Life | 1 | 2019 | 1585 | 0.100 |
Why?
|
| Adolescent | 13 | 2013 | 8981 | 0.100 |
Why?
|
| Pyridoxal Phosphate | 2 | 2000 | 13 | 0.100 |
Why?
|
| Edetic Acid | 2 | 2000 | 43 | 0.090 |
Why?
|
| Forecasting | 2 | 2003 | 304 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 3 | 2008 | 274 | 0.090 |
Why?
|
| Phosphates | 1 | 2011 | 160 | 0.090 |
Why?
|
| Cysts | 3 | 1995 | 104 | 0.090 |
Why?
|
| Catheterization | 2 | 1999 | 232 | 0.090 |
Why?
|
| Hyperplasia | 2 | 1987 | 148 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 3 | 2005 | 177 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2010 | 334 | 0.090 |
Why?
|
| Thrombosis | 1 | 1992 | 296 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2006 | 797 | 0.090 |
Why?
|
| Posture | 2 | 2006 | 125 | 0.080 |
Why?
|
| Bias | 1 | 2009 | 127 | 0.080 |
Why?
|
| Pharynx | 2 | 1985 | 45 | 0.080 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2008 | 1 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 363 | 0.080 |
Why?
|
| Iohexol | 2 | 1998 | 26 | 0.080 |
Why?
|
| Ovarian Cysts | 1 | 2008 | 17 | 0.080 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2008 | 23 | 0.080 |
Why?
|
| Linear Models | 1 | 2009 | 421 | 0.080 |
Why?
|
| Nephrolithiasis | 1 | 2008 | 22 | 0.080 |
Why?
|
| Deglutition | 2 | 1985 | 73 | 0.080 |
Why?
|
| Consumer Behavior | 1 | 2008 | 29 | 0.080 |
Why?
|
| Pharyngeal Diseases | 1 | 1988 | 11 | 0.080 |
Why?
|
| Hernia, Hiatal | 1 | 2008 | 30 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1994 | 1313 | 0.080 |
Why?
|
| Angiography | 7 | 1987 | 208 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2008 | 47 | 0.080 |
Why?
|
| Hemangioma, Cavernous | 1 | 1988 | 69 | 0.080 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 107 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2013 | 2261 | 0.070 |
Why?
|
| Teaching | 1 | 2008 | 147 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2008 | 125 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2008 | 112 | 0.070 |
Why?
|
| Quinidine | 1 | 1986 | 11 | 0.070 |
Why?
|
| Clinical Trials as Topic | 3 | 2012 | 1169 | 0.070 |
Why?
|
| Splenic Diseases | 1 | 1986 | 16 | 0.070 |
Why?
|
| Benzylamines | 1 | 2006 | 16 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2006 | 57 | 0.070 |
Why?
|
| Esophageal Diseases | 1 | 1986 | 26 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2006 | 153 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 369 | 0.070 |
Why?
|
| Azetidines | 1 | 2006 | 36 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1995 | 1373 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2006 | 59 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 636 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2007 | 227 | 0.070 |
Why?
|
| Mucocele | 1 | 1985 | 4 | 0.070 |
Why?
|
| Automation | 2 | 2006 | 106 | 0.070 |
Why?
|
| Larynx | 1 | 1985 | 38 | 0.070 |
Why?
|
| Urologic Surgical Procedures | 1 | 2006 | 146 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 351 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 455 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1991 | 1076 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 751 | 0.060 |
Why?
|
| Confusion | 1 | 2024 | 7 | 0.060 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 27 | 0.060 |
Why?
|
| Cystadenocarcinoma | 1 | 1983 | 12 | 0.060 |
Why?
|
| Cystadenoma | 1 | 1983 | 19 | 0.060 |
Why?
|
| Hemangioendothelioma | 1 | 1983 | 9 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2002 | 3640 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2006 | 240 | 0.060 |
Why?
|
| Subtraction Technique | 1 | 2004 | 133 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2006 | 208 | 0.060 |
Why?
|
| Injections, Intravenous | 3 | 2000 | 244 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2024 | 213 | 0.060 |
Why?
|
| Age Factors | 3 | 2012 | 1851 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2003 | 40 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2006 | 408 | 0.050 |
Why?
|
| Swine | 2 | 1997 | 555 | 0.050 |
Why?
|
| Research | 1 | 2004 | 253 | 0.050 |
Why?
|
| Hamartoma | 3 | 1987 | 31 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 288 | 0.050 |
Why?
|
| Heart Aneurysm | 1 | 1981 | 22 | 0.050 |
Why?
|
| Cause of Death | 1 | 2003 | 277 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2002 | 67 | 0.050 |
Why?
|
| CA-125 Antigen | 1 | 2001 | 22 | 0.050 |
Why?
|
| Gastroenterology | 1 | 2003 | 134 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2000 | 60 | 0.050 |
Why?
|
| Disease Progression | 2 | 2005 | 1531 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2020 | 66 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1987 | 220 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2001 | 121 | 0.050 |
Why?
|
| Stents | 1 | 2002 | 377 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2019 | 15 | 0.040 |
Why?
|
| Hepatic Artery | 1 | 1999 | 83 | 0.040 |
Why?
|
| Ileostomy | 1 | 2019 | 30 | 0.040 |
Why?
|
| Body Fluids | 1 | 1999 | 36 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2018 | 1823 | 0.040 |
Why?
|
| Stomach Neoplasms | 2 | 1994 | 266 | 0.040 |
Why?
|
| Renal Veins | 1 | 1998 | 28 | 0.040 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 1998 | 17 | 0.040 |
Why?
|
| Renal Artery Obstruction | 1 | 1998 | 39 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1998 | 92 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 454 | 0.040 |
Why?
|
| Abdomen | 1 | 1998 | 122 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1998 | 100 | 0.040 |
Why?
|
| Ureter | 1 | 1998 | 92 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 1999 | 184 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 410 | 0.040 |
Why?
|
| Reoperation | 1 | 2019 | 597 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 1981 | 760 | 0.040 |
Why?
|
| Adenoma, Islet Cell | 1 | 1995 | 28 | 0.030 |
Why?
|
| Acidosis, Lactic | 1 | 1995 | 12 | 0.030 |
Why?
|
| Recurrence | 1 | 1999 | 1139 | 0.030 |
Why?
|
| Contraindications | 1 | 1995 | 72 | 0.030 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1995 | 15 | 0.030 |
Why?
|
| Solubility | 1 | 1996 | 177 | 0.030 |
Why?
|
| Survival Rate | 2 | 2013 | 1863 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 5417 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 989 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 2438 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 685 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2005 | 1939 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 1995 | 299 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1995 | 138 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 7993 | 0.030 |
Why?
|
| Jejunal Neoplasms | 1 | 1994 | 9 | 0.030 |
Why?
|
| Child | 6 | 1987 | 6927 | 0.030 |
Why?
|
| Pneumoperitoneum | 1 | 1993 | 4 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 1995 | 486 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 429 | 0.030 |
Why?
|
| Animals | 5 | 1997 | 26582 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 3679 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1987 | 318 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 1995 | 295 | 0.030 |
Why?
|
| Biliary Tract | 1 | 1991 | 13 | 0.030 |
Why?
|
| Gastric Lavage | 1 | 2011 | 3 | 0.030 |
Why?
|
| Acute Disease | 1 | 1993 | 826 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1961 | 0.020 |
Why?
|
| Endoscopy | 1 | 1994 | 332 | 0.020 |
Why?
|
| Infant | 3 | 1987 | 3047 | 0.020 |
Why?
|
| Cholangiography | 1 | 1990 | 41 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 307 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2011 | 129 | 0.020 |
Why?
|
| Dogs | 1 | 1990 | 685 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2010 | 225 | 0.020 |
Why?
|
| Europe | 1 | 2009 | 309 | 0.020 |
Why?
|
| Child, Preschool | 4 | 1987 | 3612 | 0.020 |
Why?
|
| Syndrome | 1 | 1989 | 446 | 0.020 |
Why?
|
| Mesenteric Cyst | 1 | 1987 | 1 | 0.020 |
Why?
|
| Lymphangioma | 1 | 1987 | 15 | 0.020 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1987 | 11 | 0.020 |
Why?
|
| Brunner Glands | 1 | 1987 | 1 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 1987 | 32 | 0.020 |
Why?
|
| Omentum | 1 | 1987 | 71 | 0.020 |
Why?
|
| Neurofibroma | 1 | 1987 | 11 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 1987 | 24 | 0.020 |
Why?
|
| Mesenchymoma | 1 | 1986 | 4 | 0.020 |
Why?
|
| Lipoma | 1 | 1987 | 25 | 0.020 |
Why?
|
| Neurilemmoma | 1 | 1987 | 34 | 0.020 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 1986 | 8 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1186 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 2006 | 15 | 0.020 |
Why?
|
| Candidiasis | 1 | 1986 | 36 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1986 | 116 | 0.020 |
Why?
|
| Palate, Soft | 1 | 1985 | 5 | 0.020 |
Why?
|
| Epiglottis | 1 | 1985 | 6 | 0.020 |
Why?
|
| Rabbits | 1 | 1987 | 636 | 0.020 |
Why?
|
| Risk | 1 | 2007 | 674 | 0.020 |
Why?
|
| Vocal Cords | 1 | 1985 | 25 | 0.020 |
Why?
|
| Videotape Recording | 1 | 1985 | 47 | 0.020 |
Why?
|
| Tongue | 1 | 1985 | 57 | 0.020 |
Why?
|
| Warfarin | 1 | 2006 | 103 | 0.020 |
Why?
|
| Spleen | 1 | 1986 | 430 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1986 | 121 | 0.020 |
Why?
|
| Pneumoradiography | 1 | 2005 | 3 | 0.020 |
Why?
|
| Tablets | 1 | 1986 | 118 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1985 | 283 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 1987 | 2380 | 0.020 |
Why?
|
| Ileum | 1 | 1985 | 159 | 0.020 |
Why?
|
| Body Weight | 1 | 2006 | 459 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2005 | 281 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 14 | 0.020 |
Why?
|
| Crohn Disease | 1 | 1991 | 730 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2005 | 237 | 0.020 |
Why?
|
| Fuzzy Logic | 1 | 2004 | 15 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 1986 | 117 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 594 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 407 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2007 | 359 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1983 | 15 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1983 | 62 | 0.010 |
Why?
|
| Hemangiosarcoma | 1 | 1983 | 17 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 1985 | 158 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1985 | 552 | 0.010 |
Why?
|
| Biopsy | 1 | 1987 | 1163 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2501 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 1204 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 66 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1983 | 110 | 0.010 |
Why?
|
| Drainage | 1 | 1983 | 157 | 0.010 |
Why?
|
| Angiocardiography | 1 | 1981 | 31 | 0.010 |
Why?
|
| Heart Rupture | 1 | 1981 | 9 | 0.010 |
Why?
|
| Carcinoma | 1 | 1985 | 436 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1982 | 222 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2005 | 930 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1376 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 971 | 0.010 |
Why?
|
| Vomiting | 1 | 2000 | 193 | 0.010 |
Why?
|
| Pain | 1 | 2000 | 391 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 429 | 0.010 |
Why?
|
| Necrosis | 1 | 1995 | 204 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1999 | 1078 | 0.010 |
Why?
|
| Methods | 1 | 1993 | 152 | 0.010 |
Why?
|
| Heart Failure | 1 | 1983 | 1204 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 2894 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 2262 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2000 | 827 | 0.010 |
Why?
|
| Cholecystitis | 1 | 1991 | 15 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 1991 | 34 | 0.010 |
Why?
|
| Lithotripsy | 1 | 1991 | 41 | 0.010 |
Why?
|
| Cholestasis | 1 | 1991 | 47 | 0.010 |
Why?
|
| Urography | 1 | 1986 | 45 | 0.000 |
Why?
|
| Manometry | 1 | 1986 | 43 | 0.000 |
Why?
|
| Pressure | 1 | 1986 | 165 | 0.000 |
Why?
|
| Video Recording | 1 | 1984 | 190 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1986 | 459 | 0.000 |
Why?
|
| Aortography | 1 | 1982 | 63 | 0.000 |
Why?
|
| Aortic Valve Stenosis | 1 | 1982 | 131 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1986 | 2232 | 0.000 |
Why?
|